Shiitake Mushroom (Lentinula edodes)

Lentinula edodes
Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Shiitake is one of the most widely consumed culinary mushrooms globally — also extensively studied medicinally for its lentinan beta-glucan polysaccharide. Lentinan is approved as ADJUNCT CHEMOTHERAPY in Japan for stomach cancer (since 1985) — among the few mushroom compounds with prescription drug status. Used for immune support, cardiovascular health, and antioxidant effects. AHCC (an extract category) overlaps with shiitake research.

Studied Dose 1,000-3,000 mg/day mushroom extract; lentinan is typically given INJECTABLY (1-2 mg/week IV/IM) for oncology; oral lentinan absorption limited
Active Compound Lentinan (1,3-beta-glucan), eritadenine, ergosterol (vitamin D2 precursor), polyphenols

Benefits

Lentinan as Cancer Adjunct (Japan)

Lentinan has been APPROVED PRESCRIPTION DRUG in Japan since 1985 as adjunct to chemotherapy for stomach cancer — given by injection. Multiple Japanese trials support extending survival in advanced gastric cancer. One of the most clinically-validated mushroom-derived compounds. Note: oral lentinan has limited absorption; injectable form drives evidence.

Cholesterol-Lowering (Eritadenine)

Shiitake contains ERITADENINE — a unique compound that lowers cholesterol via interference with phospholipid metabolism (specifically S-adenosyl methionine cycle). Animal studies show ~25% LDL reduction. Human evidence more modest.

Immune Modulation

Beta-glucans activate innate immunity — NK cells, macrophages, dendritic cells. Modest evidence for reduced respiratory infection severity.

Antioxidant Activity

Polyphenols, ergothioneine (sulfur amino acid antioxidant), and other compounds contribute to antioxidant capacity. Ergothioneine particularly notable as essentially mushroom-exclusive antioxidant.

Vitamin D Source (UV-Exposed)

Shiitake (and other mushrooms) contain ERGOSTEROL that converts to ERGOCALCIFEROL (vitamin D2) when exposed to UV light. UV-treated shiitake (commercially available) provides meaningful vitamin D2 — among few non-animal vitamin D sources.

Mechanism of action

1

Lentinan Immune Activation

Lentinan is a 1,3-beta-glucan that activates dectin-1 and complement receptor pathways on immune cells. Activates Th1 cellular immunity and NK cell function. Mechanism well-characterized — basis for cancer adjunct evidence.

2

Eritadenine Cholesterol Mechanism

Eritadenine (2(R),3(R)-dihydroxy-4-(9-adenyl)-butyric acid) interferes with hepatic phospholipid biosynthesis — alters lipoprotein metabolism. Unique mechanism distinct from statins or other cholesterol drugs.

3

Ergothioneine Antioxidant

Ergothioneine is a sulfur-containing amino acid found almost exclusively in mushrooms (and bacteria/fungi). Acts as cellular antioxidant; concentrated in tissues with high oxidative stress (kidney, liver, RBCs).

4

UV Conversion to Vitamin D2

Ergosterol in mushrooms converts to ergocalciferol (D2) when exposed to UV light. UV-exposed shiitake can provide significant D2 (manufacturers sun-dry or UV-treat for this purpose).

Clinical trials

1
Lentinan for Gastric Cancer — Japanese Trials
PubMed

Multiple Japanese RCTs and post-marketing studies of injectable lentinan (1-2 mg IV/week) as adjunct to chemotherapy in advanced gastric cancer.

Advanced gastric cancer patients.

Improved survival when added to chemotherapy. Approved by Japanese authorities as prescription adjunct cancer drug since 1985. CRITICAL: injectable formulation; oral lentinan has limited absorption.

2
Shiitake Whole Food Immune Effects — Dai 2015
PubMed

Trial of whole shiitake mushroom consumption (5-10 g/day) for 4 weeks in healthy adults. Outcomes: immune cell function, inflammation markers.

Healthy adults.

Improved gamma delta T-cell and NK cell function, reduced inflammatory markers. Supports general immune-supportive role of dietary shiitake.

Side effects and drug interactions

Common Potential side effects

SHIITAKE DERMATITIS — characteristic 'whiplash' linear streaks rash from RAW or undercooked shiitake; well-documented; resolves spontaneously; cook shiitake thoroughly before consumption.
GI distress (especially raw mushroom).
Allergic reactions to mushroom.
Bleeding risk — modest at high doses.
Lentinan injection: fever, chills, GI distress (well-documented; manageable).

Important Drug interactions

Anticoagulants — theoretical bleeding risk at high doses.
Immunosuppressants — beta-glucan immune activation could theoretically interfere; AVOID in transplant patients.
Chemotherapy — adjunctive use in Japan; consult oncologist.
Hypotensives — modest additive effects.

Frequently asked questions about Shiitake Mushroom (Lentinula edodes)

What is Shiitake Mushroom (Lentinula edodes)?

Shiitake is one of the most widely consumed culinary mushrooms globally — also extensively studied medicinally for its lentinan beta-glucan polysaccharide.

What does Shiitake Mushroom (Lentinula edodes) do?

Lentinan is a 1,3-beta-glucan that activates dectin-1 and complement receptor pathways on immune cells. Activates Th1 cellular immunity and NK cell function. Mechanism well-characterized — basis for cancer adjunct evidence. In clinical research, Shiitake Mushroom (Lentinula edodes) has been studied for lentinan as cancer adjunct (japan), cholesterol-lowering (eritadenine), immune modulation.

Who should take Shiitake Mushroom (Lentinula edodes)?

Shiitake Mushroom (Lentinula edodes) may be most relevant for people interested in immune support, cardiovascular. It has been clinically studied for lentinan as cancer adjunct (japan), cholesterol-lowering (eritadenine), immune modulation. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Shiitake Mushroom (Lentinula edodes) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Shiitake Mushroom (Lentinula edodes)?

For immune support, Shiitake Mushroom (Lentinula edodes) can typically be taken in the morning with breakfast. For acute illness use, follow product labeling — dosing frequency and timing may differ from preventive use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Shiitake Mushroom (Lentinula edodes) worth taking?

Shiitake Mushroom (Lentinula edodes) has strong clinical evidence (Evidence Level 4/5 on NutraSmarts) for its primary uses, with multiple randomized controlled trials and meta-analyses supporting its benefits. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Shiitake Mushroom (Lentinula edodes) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Shiitake Mushroom (Lentinula edodes)?

The clinically studied dose for Shiitake Mushroom (Lentinula edodes) is 1,000-3,000 mg/day mushroom extract; lentinan is typically given INJECTABLY (1-2 mg/week IV/IM) for oncology; oral lentinan absorption limited. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Shiitake Mushroom (Lentinula edodes) used for?

Shiitake Mushroom (Lentinula edodes) is studied for lentinan as cancer adjunct (japan), cholesterol-lowering (eritadenine), immune modulation. Lentinan has been APPROVED PRESCRIPTION DRUG in Japan since 1985 as adjunct to chemotherapy for stomach cancer — given by injection. Multiple Japanese trials support extending survival in advanced gastric cancer.